| abstract |
Disclosed are pharmaceutical compositions, methods, and kits comprising metformin R-(+) lipoate and an antihypertensive agent or a pharmaceutically acceptable salt, hydrate, solvate and prodrug derivative thereof for the treatment of Type 2 diabetic hyperglycemia and diabetic complications. |